Last reviewed · How we verify
NCT05612412
Exercise for Better Bones - Day or Night?
NA trial testing Morning Exercise in Overweight in 2 participants. Terminated before completion.
30 July 2024
Quick facts
| Lead sponsor | USDA Grand Forks Human Nutrition Research Center |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 2 |
| Start date | 5 October 2023 |
| Primary completion | 30 July 2024 |
| Estimated completion | 30 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Morning Exercise
- Evening Exercise
Conditions studied
- Overweight — all drugs for Overweight →
Sponsor
USDA Grand Forks Human Nutrition Research Center
Who can join
Adults 45 to 65, female only, with Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to find out if moderate exercise at different time during the day (early morning vs early evening) affects biomarker CTX of bone health in normal to overweight postmenopausal women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05612412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Morning Exercise
Trials testing the same drug.
- NCT06555627 — Embracing Morning BReakfast and Activity for Classroom Engagement · NA · recruiting
- NCT06336590 — Student Exercise and Sleep Timing Study - Part 2 · NA · recruiting
- NCT05963152 — Resistance Exercise and Cognition in People With Type 1 Diabetes · NA · unknown
- NCT05153252 — Timing Intervention of Morning Versus Evening Exercise · NA · recruiting
- NCT05108987 — Exercise and Time of Day in Type 2 Diabetes · NA · recruiting
Other recruiting trials for Overweight
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
- NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
- NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting
Other USDA Grand Forks Human Nutrition Research Center trials
Trials by the same sponsor.
- NCT06674642 — Traditional Indigenous Foods Diet and Health Study · NA · completed
- NCT06123208 — Impact of Eating Beans on Metabolism · NA · completed
- NCT05938894 — Train Your Brain - Executive Function · NA · completed
- NCT06096636 — National Survey of Young Adult Nutrition · completed
- NCT05888779 — Beverages for Thought: Exploring the Relationship Between Blood Glucose and Cognition · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05612412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by USDA Grand Forks Human Nutrition Research Center
- Last refreshed: 11 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05612412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing